$KNSA 3 SEC Filings

Filed On	Filing
06 Jul 2026	Form 3: Malkani Dhiraj H, CHIEF STRATEGY OFFICER No securities owned
08 Oct 2024	Form 3: Boyd Meta Cantey, Director No securities owned
21 Jun 2021	Form 3: Pano Arian, Chief Clinical Dev. Officer Holds 1,539 shares of Class A Common Shares
21 Jun 2021	Form 3: Tessari Eben, Chief Business Officer Holds 105,942 shares of Class A Common Shares
15 Apr 2021	Form 3: Moat Ross, Group VP & Rilonacept GM Holds 3,382 shares of Class A Common Shares
23 Dec 2020	Form 3: Ragosa Mark, Interim CFO
29 Jul 2020	Form 3: Cole G Bradley, Director No securities owned
13 Feb 2020	Form 3: Megna Michael R, Chief Accounting Officer Holds 1,137 shares of Class A Common Shares
25 Nov 2019	Form 3: Rizvi Qasim, Chief Commercial Officer
06 Mar 2019	Form 3: Levy Richard S, Director No securities owned
23 May 2018	Form 3: Boess Carsten, 10% owner Holds 73,197 shares of Class A Common Shares
23 May 2018	Form 3: Beetham Thomas W., Chief Legal Officer Holds 73,197 shares of Class A Common Shares
23 May 2018	Form 3: Heberlig Chris, Exec VP & CFO Holds 36,599 shares of Class A Common Shares
23 May 2018	Form 3: Patel Sanj K, Director Holds 109,796 shares of Class A Common Shares
23 May 2018	Form 3: Flynn James E, 10% owner and 3 others
23 May 2018	Form 3: Baker Bros. Advisors Lp, Director and 5 others
23 May 2018	Form 3: Biggar Stephen R, Director No securities owned
23 May 2018	Form 3: Paolini John, Chief Medical Officer
23 May 2018	Form 3: Quart Barry D, Director
23 May 2018	Form 3: Mahoney Stephen F., President & COO Holds 73,197 shares of Class A Common Shares

Comments